Apigenin, GABAergic signaling, and sleep-related behavior
Sedation potential retained from the sleep-oriented safety seed.
This source supports safety, monitoring, or interaction context for the safety profile.
Durable audit route for one claim-like target. This page shows source-use records, assessment rationale, active challenges, revisions, and graph edges tied to the same target identity.
Sedation / drowsiness is included with provisional confidence because the record has direct section evidence but still needs endpoint-specific interpretation before it should be read as a strong clinical claim.
The assessment is anchored to the cited clinical guidance record rather than inferred from the compound name alone.
Sources considered for this assessment[1]
The row has an explicit structured record and citation mapping.
The current seed evidence does not yet carry the same detailed endpoint interpretation as Taurine.
The audit path is present; additional source interpretation can be added without changing the schema.
Sedation potential retained from the sleep-oriented safety seed.
This source supports safety, monitoring, or interaction context for the safety profile.